Baseline geriatric 8 (G8) screening tool to predict overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitors.

被引：0
|
作者：
Rhee, Christopher H.
Goyal, Subir
Liu, Yuan
Martini, Dylan J.
Nazha, Bassel
Kucuk, Omer
Carthon, Bradley Curtis
Bilen, Mehmet Asim
Brown, Jacqueline T.
机构：
[1] Augusta Univ Univ Georgia Med Partnership, Augusta, GA USA
[2] Emory Univ, Dept Biostat & Bioinformat, Sch Med, Atlanta, GA USA
[3] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Emory Univ, Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16575
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Evaluating intermediate endpoints for overall survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors: an IMDC study
    Saliby, Renee Maria
    Xie, Wanling
    Wells, Connor J.
    Saad, Eddy
    Eid, Marc
    Semaan, Karl
    Labaki, Chris
    Ferrier, Evan
    Zarba, Martin
    Ebrahimi, Hedyeh
    Ravi, Praful
    Suarez, Cristina
    Morales, Jose Ruiz
    Mckay, Rana R.
    Powles, Thomas
    Wood, Lori
    Lalani, Aly-Khan A.
    Pal, Sumanta K.
    de Velasco, Guillermo
    Takemura, Kosuke
    Agarwal, Neeraj
    Braun, David A.
    Heng, Daniel Y.
    Choueiri, Toni K.
    ONCOLOGIST, 2024, 29
  • [22] Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
    Maiorano, Brigida Anna
    Di Maio, Massimo
    Cerbone, Linda
    Maiello, Evaristo
    Procopio, Giuseppe
    Roviello, Giandomenico
    JAMA NETWORK OPEN, 2024, 7 (03) : E241215
  • [23] Comparison of retroperitoneal laparoscopic radical nephroureterectomy outcomes in elderly patients based on the Geriatric 8 (G8) screening tool
    Hikita, Katsuya
    Honda, Masashi
    Shimizu, Naru
    Kanzawa, Kazuyoshi
    Osaki, Hiroki
    Koyama, Yuri
    Yamamoto, Atsushi
    Yamane, Hiroshi
    Shimizu, Ryutaro
    Nishikawa, Ryoma
    Omatsu, Rumiko
    Kimura, Yusuke
    Yamaguchi, Noriya
    Morizane, Shuichi
    Takenaka, Atsushi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2025,
  • [24] Immune-related adverse events can predict progression-free and overall survival in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Silberg, Matteo
    Krabbe, Laura-Maria
    Boegemann, Martin
    Schrader, Andres Jan
    Schlack, Katrin
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 103 - 103
  • [25] Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors
    Silberg, Matteo
    Krabbe, Laura-Maria
    Boegemann, Martin
    Schrader, Andres Jan
    Tully, Karl
    Schlack, Katrin
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [26] Comparing overall survival of patients with metastatic uveal melanoma by sequence of Tebentafusp versus combination immune checkpoint inhibitors.
    Shikdar, Sufana
    Day, Silas
    Ikeguchi, Alexandra
    Ying, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Validation of the VIO prognostic index in patients with metastatic urothelial carcinoma treated with immune-checkpoint inhibitors
    Morales Barrera, R.
    Matos, I.
    Gonzalez, M.
    Suarez, C.
    Ros, J.
    Valverde, C.
    Fernandez, C.
    Hierro, C.
    Serra, E.
    Mateo, J.
    Gutierrez, S.
    Martin Liberal, J.
    Quintana, A.
    Dienstmann, R.
    Serrano, C.
    Garralda, E.
    Carles, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 369 - +
  • [28] COMBINATION OF NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) AND G8 SCREENING TOOL IS USEFUL TO PREDICT OVERALL SURVIVAL OF ELDERLY PATIENTS WITH CHEMOTHERAPY FOR UNRESECTABLE/RECURRENT GASTRIC CANCER
    Kitayama, Yoshitaka
    Tozawa, Katsuyuki
    Fukui, Hirokazu
    Hara, Ken
    Kondo, Takashi
    Tomita, Toshihiko
    Ohda, Yoshio
    Oshima, Tadayuki
    Watari, Jiro
    Miwa, Hiroto
    GASTROENTEROLOGY, 2018, 154 (06) : S934 - S934
  • [29] Baseline systemic inflammatory immune index may predict overall survival and progression-free survival in patients with non-small cell lung cancer patients on immune checkpoint inhibitors.
    Palmer, John P.
    Cao, Yenong
    Ibrahim, Samer
    Dhawan, Natasha
    Afzal, Muhammad Zubair
    Shirai, Keisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Prospective evaluation of the G8 screening tool for predicting survival in elderly patients with colon cancer
    Soler, G.
    Legido, R.
    Perez, X.
    Martinez-Villacampa, M.
    Santos, C.
    Losa, F.
    Ruffinelli, J. C.
    Mulet, N.
    Teule, A.
    Castany, R.
    Gallego, R.
    Carbonell, M.
    Manzana, A.
    Rios, A.
    Saldana, J.
    Salazar, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S457 - S457
12345